FFilingSight

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.

Aug 14, 2026 · FilingSight Research

Market Brief — August 14, 2026

Risk-on · Supportive. 26 Buy / 130 Hold / 26 Sell across 182 names. Top conviction: INTU.

MacroDaily BriefRates

Market Brief — August 14, 2026

Auto-generated by FilingSight from live FRED macro data and the latest SEC-derived company reports.

Macro regime

Risk-on · Supportive.

Gauge Status Detail
Growth & Recession Gauge Mixed / caution Mixed / caution. Payrolls softening.
Inflation Regime Moderating Moderating. Headline CPI +3.3% YoY, core +2.5% YoY; 5Y breakeven 2.21%.
Financial Conditions Neutral Neutral. VIX 14.55, BAA-10Y credit spread 1.66pp.
Policy Stance Near neutral Near neutral. Fed funds 3.63%, real rate 1.16%.

Rates & inflation

Fed funds 3.63%, headline CPI YoY 3.3%, VIX 14.6, yield curve upward-sloping.

Coverage breadth

Across 182 tracked names: 26 bullish, 130 neutral, 26 bearish outlook.

Highest-conviction bullish names:

  • INTU (Intuit Inc.) — Buy, composite score 35, confidence 83%.
  • CF (CF Industries) — Buy, composite score 31, confidence 82%.
  • ALL (Allstate Corp.) — Buy, composite score 30, confidence 81%.
  • BKNG (Booking Holdings) — Buy, composite score 30, confidence 83%.

Most bearish names:

  • TSLA (Tesla Inc.) — Sell, score -39.
  • ON (ON Semiconductor Corp.) — Sell, score -35.
  • DOW (Dow Inc.) — Sell, score -30.

What to watch

With the macro backdrop firmly risk-on, supported by a 3.3% CPI print, an upward-sloping curve, and a subdued 14.6 VIX, tracked positioning remains overwhelmingly defensive in conviction despite the supportive Fed funds rate at 3.63%. Investors should monitor whether the 130-to-26 Hold-to-Buy ratio breaks toward active accumulation, with current top buys INTU, CF, ALL, and BKNG signaling preference for secular growth and cyclical insurance over broad-based risk-taking. A sustained shift in breadth toward the 26 Sell names would mark the first indication that the supportive regime is fatiguing.


FilingSight is informational and educational only, generated from public data. Not investment advice.